{"id":139140,"date":"2024-11-19T13:39:10","date_gmt":"2024-11-19T08:09:10","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=139140"},"modified":"2024-11-19T13:39:12","modified_gmt":"2024-11-19T08:09:12","slug":"pharma-stock-hits-5-upper-circuit-after-signing-sales-agreement-with-south-korean-company","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-5-upper-circuit-after-signing-sales-agreement-with-south-korean-company\/","title":{"rendered":"Pharma stock hits 5% upper circuit after signing sales agreement with South Korean company"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-2873981809\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>This Pharma stock is engaged in pharmaceutical contract development and manufacturing organization and offers a range of pharmaceutical products and services entered into an agreement with a leading South Korean company for Nutraceuticals.<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-2118431883\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Price Action&nbsp;<\/strong><\/h2><p>With a market capitalization of Rs. 9,144 Crores, the shares of <strong><a href=\"https:\/\/portal.tradebrains.in\/stocks\/AKUMS\" target=\"_blank\" rel=\"noreferrer noopener\">Akums Drugs and Pharmaceuticals Limited<\/a><\/strong> hit a 5 percent upper circuit in the day\u2019s trade at Rs. 580.95 per equity share, from its previous day\u2019s close price of Rs. 553.30. The stock was recently listed on the bourses with a price of Rs. 725 apiece which was 6.77 percent higher from the issue price of Rs. 679 per share. From the day of listing the stock has underperformed the nifty index.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>What Happened&nbsp;<\/strong><\/h2><p>Akums Drugs and Pharmaceuticals Limited has entered into a master sales agreement with Caregen company which is a South Korean based focused on the Nutraceuticals segment.&nbsp;<\/p><p>Akums have been granted exclusive rights to sell certain products of Caregen in India for the agreement term. Further Akums would also undertake marketing, packaging, and selling of Caregen\u2019s bulk product under Caregen\u2019s trademark or Akum\u2019s trademark, or Akums client&#8217;s trademark.<\/p><div class=\"trade-content_5\" id=\"trade-1255506205\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>Caregen is a biotechnology company based in South Korea leading in research and development and has commercialized using patents.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>About the Company&nbsp;<\/strong><\/h2><p>Akums Drugs &amp; Pharmaceuticals Limited, established in 2004, is a leading Contract Development and Manufacturing Organization in India. The company specializes in producing a wide range of pharmaceutical products, including tablets, capsules, and injectables.&nbsp;<\/p><p>Their business model focuses on innovation through extensive R&amp;D, regulatory compliance, and high-quality manufacturing processes. Akums serves both domestic and international markets, focusing on customized solutions for clients while maintaining a commitment to safety and efficacy. With multiple manufacturing facilities and a strong track record, Akums aims to enhance patient care by delivering reliable and effective healthcare solutions across various therapeutic areas.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Financials &amp; Ratios&nbsp;<\/strong><\/h2><p>Its Revenue from operations declined by 12.5 percent year on year from Rs. 1,181.25 Crores in Q2FY24 to Rs. 1,033.09 Crores in Q2FY25, accompanied by profits of Rs. 2.22 Crores to Rs. 4.37 Crores.&nbsp;<\/p><p>In terms of Return ratios, it has reported a return on equity (ROE) of -3.57 percent and a return on capital employed (ROCE) of 1.24 percent. It has reported a debt-to-equity ratio of 0.83.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Shareholding Pattern<\/strong><\/h2><p>As of September 2024, the shareholding pattern with promoters stake holding a major share of 75.26 percent in Akums Drugs and Pharmaceuticals, Foreign Institutional Investors (FII) holding around 7.34 percent,&nbsp; Domestic Institutional investors (DII) standing at 7.52 percent, and public holdings standing at 9.88 percent.<\/p><div class=\"trade-content-10\" id=\"trade-2016177850\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written by Santhosh S&nbsp;<\/strong><\/p><\/blockquote><h2 class=\"wp-block-heading\" id=\"h-disclaimer\"><strong>Disclaimer<\/strong><\/h2><div class=\"wp-block-image\"><figure class=\"aligncenter\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on&nbsp;<a href=\"https:\/\/tradebrains.in\/\">tradebrains.in<\/a>&nbsp;are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing<\/strong>.<\/p><div class=\"trade-after-content\" id=\"trade-475456804\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>This Pharma stock is engaged in pharmaceutical contract development and manufacturing organization and offers a range of pharmaceutical products and services entered into an agreement with a leading South Korean company for Nutraceuticals. Price Action&nbsp; With a market capitalization of Rs. 9,144 Crores, the shares of Akums Drugs and Pharmaceuticals Limited hit a 5 percent [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":98971,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[24712,24711,23746,948,936],"class_list":["post-139140","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-akums-drugs","tag-akums-drugs-and-pharmaceuticals-limited","tag-akums-drugs-and-pharmaceuticals-limited-latest-news","tag-stock-market","tag-stock-market-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock hits 5% upper circuit after signing sales agreement with South Korean company - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"This Pharma stock is engaged in pharmaceutical contract development and manufacturing organization and offers a range of pharmaceutical products and services entered into an agreement with a leading South Korean company for Nutraceuticals.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-5-upper-circuit-after-signing-sales-agreement-with-south-korean-company\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock hits 5% upper circuit after signing sales agreement with South Korean company\" \/>\n<meta property=\"og:description\" content=\"This Pharma stock is engaged in pharmaceutical contract development and manufacturing organization and offers a range of pharmaceutical products and services entered into an agreement with a leading South Korean company for Nutraceuticals.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-5-upper-circuit-after-signing-sales-agreement-with-south-korean-company\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-19T08:09:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-19T08:09:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-5-upper-circuit-after-signing-sales-agreement-with-south-korean-company\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-5-upper-circuit-after-signing-sales-agreement-with-south-korean-company\/\",\"name\":\"Pharma stock hits 5% upper circuit after signing sales agreement with South Korean company - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-5-upper-circuit-after-signing-sales-agreement-with-south-korean-company\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-5-upper-circuit-after-signing-sales-agreement-with-south-korean-company\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"datePublished\":\"2024-11-19T08:09:10+00:00\",\"dateModified\":\"2024-11-19T08:09:12+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"This Pharma stock is engaged in pharmaceutical contract development and manufacturing organization and offers a range of pharmaceutical products and services entered into an agreement with a leading South Korean company for Nutraceuticals.\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-5-upper-circuit-after-signing-sales-agreement-with-south-korean-company\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-5-upper-circuit-after-signing-sales-agreement-with-south-korean-company\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-5-upper-circuit-after-signing-sales-agreement-with-south-korean-company\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-5-upper-circuit-after-signing-sales-agreement-with-south-korean-company\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock hits 5% upper circuit after signing sales agreement with South Korean company\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock hits 5% upper circuit after signing sales agreement with South Korean company - Trade Brains Features","description":"This Pharma stock is engaged in pharmaceutical contract development and manufacturing organization and offers a range of pharmaceutical products and services entered into an agreement with a leading South Korean company for Nutraceuticals.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-5-upper-circuit-after-signing-sales-agreement-with-south-korean-company\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock hits 5% upper circuit after signing sales agreement with South Korean company","og_description":"This Pharma stock is engaged in pharmaceutical contract development and manufacturing organization and offers a range of pharmaceutical products and services entered into an agreement with a leading South Korean company for Nutraceuticals.","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-5-upper-circuit-after-signing-sales-agreement-with-south-korean-company\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2024-11-19T08:09:10+00:00","article_modified_time":"2024-11-19T08:09:12+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-5-upper-circuit-after-signing-sales-agreement-with-south-korean-company\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-5-upper-circuit-after-signing-sales-agreement-with-south-korean-company\/","name":"Pharma stock hits 5% upper circuit after signing sales agreement with South Korean company - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-5-upper-circuit-after-signing-sales-agreement-with-south-korean-company\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-5-upper-circuit-after-signing-sales-agreement-with-south-korean-company\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","datePublished":"2024-11-19T08:09:10+00:00","dateModified":"2024-11-19T08:09:12+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"This Pharma stock is engaged in pharmaceutical contract development and manufacturing organization and offers a range of pharmaceutical products and services entered into an agreement with a leading South Korean company for Nutraceuticals.","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-5-upper-circuit-after-signing-sales-agreement-with-south-korean-company\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-hits-5-upper-circuit-after-signing-sales-agreement-with-south-korean-company\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-5-upper-circuit-after-signing-sales-agreement-with-south-korean-company\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-5-upper-circuit-after-signing-sales-agreement-with-south-korean-company\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock hits 5% upper circuit after signing sales agreement with South Korean company"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/139140","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=139140"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/139140\/revisions"}],"predecessor-version":[{"id":139143,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/139140\/revisions\/139143"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/98971"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=139140"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=139140"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=139140"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}